Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Predictors for squamous re-epithelialization of Barrett's esophagus after endoscopic biopsy.

Journal of gastroenterology and hepatology - 1 Jun 2007

Amano Yuji, Kushiyama Yoshinori, Yuki Takafumi, Takahashi Yoshiko, Chinuki Daisuke, Ishimura Norihisa, Furuta Kenji, Ishihara Shunji, Adachi Kyoichi, Maruyama Riruke, Kinoshita Yoshikazu

Abstract excerpt

BACKGROUND AND AIM: Acid suppressive therapy has been reported to regress Barrett's esophagus. However, it is still controversial as to whether all Barrett's esophagus patients respond to this therapy. The factors that might facilitate newly developed squamous re-epithelialization after biopsy ex...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Ulcer Agents
Share to Barrett Esophagus

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Biopsy

Share to Carcinoma, Squamous Cell

Share to Chi-Square Distribution

Share to Cyclooxygenase 2 Inhibitors

Share to Esophageal Neoplasms

Share to Surveys and Questionnaires

Source

Identifiers

PMID: 17565646
DOI: 10.1111/j.1440-1746.2006.04369.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17565646-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Predictors for squamous re-epithelialization of Barrett's esophagus after endoscopic biopsy.PMID 17565646Read ↗

Dedifferentiation Precedes Invasion in the Progression from Barrett's Metaplasia to Esophageal AdenocarcinomaSemantic proximity Read ↗

Biomarker studies in reversed Barrett's esophagus.Semantic proximity Read ↗

Usefulness of endoscopic brushing and magnified endoscopy with narrow band imaging (ME-NBI) to detect intestinal phenotype in columnar-lined esophagus.Semantic proximity Read ↗

Abnormal<i>TP53</i>predicts risk of progression in patients with Barrett’s esophagus regardless of a diagnosis of dysplasiaSemantic proximity Read ↗

Modelling Barrett's oesophagus.Semantic proximity Read ↗

Prevalence of and risk factors for Barrett's esophagus with intestinal predominant mucin phenotype.Semantic proximity Read ↗

Induction of intestinalization in human esophageal keratinocytes is a multistep processSemantic proximity Read ↗

Phenotypic differences between esophageal and gastric intestinal metaplasia.Semantic proximity Read ↗

Divergent expression of MUC5AC, MUC6, MUC2, CD10, and CDX-2 in dysplasia and intramucosal adenocarcinomas with intestinal and foveolar morphology: is this evidence of distinct gastric and intestinal pathways to carcinogenesis in Barrett Esophagus?Semantic proximity Read ↗

Deoxycholic acid (DCA) confers an intestinal phenotype on esophageal squamous epithelium via induction of the stemness-associated reprogramming factors OCT4 and SOX2.Semantic proximity Read ↗

Cdx-2 expression in squamous and metaplastic columnar epithelia of the esophagus.Semantic proximity Read ↗

SOX2 as a Novel Marker to Predict Neoplastic Progression in Barrett’s EsophagusSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.